FDA label
What is efavirenz used for?
The FDA-approved uses of efavirenz, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Efavirenz in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted efavirenz?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Efavirenz, tablet, film coated
Indications and Usage, quoted from the label by Cipla USA Inc. (ANDA204766). Cross-references to other label sections are left out.
Efavirenz in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg.
Source: DailyMed label, set id 92603fa5-7a2c-4bfb-9a70-aadb4fba952c, version 7, effective March 31, 2024. NDC 69097-301, one of 4 listings for this product.
Questions
What is efavirenz used for?
The FDA label says: “Efavirenz in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg.”
What drug class is efavirenz?
FDA lists efavirenz in the Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.